Zdrowie i gospodarka · 28/05/2015

Molecular Characterization of Multiple Myeloma Black/African Ancestry Disparity

The Food and Drug Administration (FDA) is announcing the availability of grant funds to support the development of methodologies for clinical trial design evaluation in the U.S. Black population, with a focus on Multiple Myeloma. The grant will be awarded to the Multiple Myeloma Service of Memorial Sloan Kettering Cancer Institute through a cooperative agreement with the Center for Drug Evaluation and Research (CDER).